Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway
0301 basic medicine
substrate deprivation therapy
mouse model
receptor
Endocrinology, Diabetes and Metabolism
Clinical Biochemistry
open-label
I Patiens
Cell Line
Rhoamine-B
03 medical and health sciences
Humans
Pharmacology (medical)
Phosphorylation
Molecular Biology
Glycosaminoglycans
Biochemistry, medical
Epidermal Growth Factor
Estradiol
enzyme-replacement therapy
Research
R
prediction
Cell Biology
Fibroblasts
Mucopolysaccharidoses
Genistein
laronidase
3. Good health
ErbB Receptors
Medicine
Signal Transduction
DOI:
10.1186/1423-0127-16-26
Publication Date:
2009-05-28T19:17:50Z
AUTHORS (5)
ABSTRACT
Mucopolysaccharidoses (MPS) are inherited metabolic disorders caused by mutations leading to dysfunction of one enzymes involved in degradation glycosaminoglycans (GAGs). Due their impaired degradation, GAGs accumulate cells patients, which results tissues and organs. Substrate reduction therapy is potential treatment these diseases. It was demonstrated previously that genistein (4', 5, 7-trihydroxyisoflavone) inhibits synthesis reduces levels cultures fibroblasts MPS patients. Recent pilot clinical study indicated such a may be effective III (Sanfilippo syndrome).To learn on details the molecular mechanism genistein-mediated inhibition GAG synthesis, efficiency this process studied measuring incorporation labeled sulfate, storage lysosomes estimated using electron microscopic techniques, phosphorylation epidermal growth factor (EGF) receptor determined an ELISA-based assay with fluorogenic substrates.Effects accumulation from patients suffering various types were abolished presence excess EGF, partially reversed increased concentration genistein. No effects observed when 17beta-estradiol used instead EGF. Moreover, EGF-mediated stimulation phsophorylation EGF both wild-type fibroblasts.The presented report indicate operates through (EGF)-dependent pathway.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (28)
CITATIONS (91)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....